In June 2015 a mom from Independence Louisiana was among the growing number of complainants filing cases against GlaxoSmithKline over the effects of their drug, Zofran, that caused birth defects in their unborn children. The Louisiana mother was prescribed Zofran as an “off-label” drug for her to use for nausea in her first trimester. The mother continued to take the drug straight through to her third trimester. The mom blamed makers of the drug for false advertisement of the drug claiming it is a “safe and effective” remedy for nausea and vomiting (NVM) that many women experience in the first twelve weeks of pregnancy. Subsequently, the mother gave birth to a son who was diagnosed with multiple congenital heart defects such as atrial septal defect and partial anomalous pulmonary venous return. Read more about this Louisiana lawsuit here.
This is not the only case filed in Louisiana, another mom filed a lawsuit against GSK who took the drug for severe morning sickness as per her doctor’s prescription, but ended up giving birth to a child with ventricular septal defect (VSD), atrial septal defect (ASD), and intermittent tachypnea. Go here for more details about this case.
Why Is Zofran Being Linked With Birth Abnormalities?
Researchers at Harvard University and Boston University’s Slone Epidemiology Center alongside the US Centers for Disease Control, analyzed data for 10,383 births. Of the group of women in this study, 15.4% were prescribed Zofran or a generic version of it in order to treat NVM during the first twelve weeks of pregnancy. The women who had been given Zofran for NVM were compared against those who had not been prescribed the drug or a generic version of it and it was discovered that those who ingested the drug in the first 12 weeks of pregnancy were 2.37 times more likely to give birth to a baby with cleft palate.
A study conducted in Denmark reviewed Danish births between 1997-2010 for an accumulated total 903,207 births. 1,368 of those pregnant women used Zofran to remedy their morning sickness in their first trimester. The result was 4.7% of those women who took Zofran delivered babies with birth abnormalities. The study reached a conclusion that revealed a 4.8 times likelihood of moms giving birth to children with a form of congenital disorder called atrioventricular septal defect.
Go here for more details about Zofran related birth abnormalities studies.
Louisiana:Figures Related To Birth Defects
It is reported that of the 62,000 babies born each year in Louisiana, at least 1,800 (1 out of 33) are born with a birth defect. This is in line with the CDC’s national statistics reporting of one in thirty three babies being born with a birth defect. In 2014 it was estimated that 4,649,676 people lived in Louisiana. The following are the recorded numbers of people who lived in Louisiana’s five major cities in 2014 as well:
- New Orleans- 378,715 population
- Baton Rouge- 229,426 population
- Shreveport- 200,327 population
- Metairie- 139,000 population
- Lafayette- 124,276 population
Zofran became available to the U.S. public in 1991 and rapidly gained popularity that caused it to have one of the most written scripts in America. So popular was Zofran that it most likely captured 99% of the market by 2005. Armed with this knowledge, our Zofran attorneys have worked out the possible data of births where Zofran may have been a culprit of the resultant birth abnormality as well as taking the average risk ratios that were recognized in clinical studies that were undertaken. For all of Louisiana, our calculations add up to 2,680 live births that were affected by the presence of Zofran in utero when taken during the first trimester.
Orofacial Cleft Deformities Vs Congenital Heart Defects Associated With Zofran In Louisiana?
Using the Louisiana population of 4,649,676, we have calculated a potential, 436 birth deformities in the form of a cleft palate, and 2,244 births with a congenital heart defect. Incorporating the data for Louisiana’s five major cities we calculated the following:
- New Orleans- 230 birth defects with roughly 38 cleft palate, and 192 congenital heart defects
- Baton Rouge- 160 birth defects with roughly 24 cleft palate, and 136 congenital heart defects
- Shreveport- 144 birth defects with roughly 19 cleft palate, and 125 congenital heart defects
- Metairie- 115 birth defects with roughly 13 cleft palate, and 102 congenital heart defects
- Lafayette- 108 birth defects with roughly 11 cleft palate, and 97 congenital heart defects
Birth Deformities & Adverse Effects That Have Been Recorded
As the Louisiana lawsuits mentioned above stated- Zofran was the cause of their babies being born with deformities such as ventricular septal defect (VSD), atrial septal defect (ASD), intermittent tachypnea and partial anomalous pulmonary venous return. These are not the only adverse effects that have been reported in cases that have been brought to court to date. These are some of the deformities that have been recorded:
- Kidney Malformations
- Cleft Palate
- Facial Dysmorphia
- Webbed Toes
- Low set ears
- Bicuspid aortic stenosis
- Supraventricular tachycardia
Parents From Louisiana Reaching Out To ZofranLegal.com
Zofranlegal.com exists to exclusively report the latest news about the Zofran lawsuit. The website’s proprietors are Monheit Law, Janet Jenner & Suggs, Grant Eisenhofer, Markhoff & Mittman, and Banville Law. Although our attorneys are not certified to practice law in the state of Louisiana, we are certified and maintain offices in Delaware. Delaware State is also where GSK holds its headquarters, which makes it a prime area for us to work with your family regarding a Zofran litigation when filed in Delaware. Click here for our Delaware office details.
Families from all over Louisiana are reaching out to us via phone calls and contact forms as they are of the impression that Zofran caused their child to be born with deformities. Upon further evaluation of your case we may advise you of several options to file your case. Your case may be filed in Delaware or another suitable location, or in Louisiana using one of our network trusted legal representatives.
Many questions are bound to arise, please reach out to us as our Zofran advocates are ready to speak to you at any time of the day.